Actinogen Limited

ASX:ACW ISIN:AU000000ACW3

 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 14177

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article▸
###

2,133 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 15) (Last 30 Days: 48) (Since Published: 2133) 

Company Data

More News Results

  • 2026/02/02: ACW secures funding beyond XanaMIA AD trial final results*
  • 2026/01/30: ACW December 2025 quarterly activity report & Appendix 4C*
  • 2026/01/30: Continuation of Trading Halt*
  • 2026/01/30: ACW positive XanaMIA Interim Analysis outcome*
  • 2026/01/29: Trading Halt*
  • 2025/12/18: ACW XanaMIA trial fully enrolled with 246th participant*
  • 2025/11/12: ACW positive XanaMIA Data Monitoring Committee meeting*
  • 2025/10/23: ACW September 2025 quarterly activity report & Appendix 4C*
  • 2025/10/20: ACW confirms eligibility for further $1.9m RDTI*
  • 2025/10/20: ACW achieves early screening closure for XanaMIA trial*
*refer to company website